2024-02-05 19:24:23 ET
Summary
- Atara Biotherapeutics is a biotech company focused on developing cell therapies for Epstein-Barr virus infection and cancer.
- Their most advanced product, tab-cel, has shown promising results in treating EBV-associated post-transplant lymphoproliferative disease.
- The company's financial situation is uncertain, but recent partnerships and potential revenue growth from tab-cel could improve their cash runway.
Topline Summary
Read the full article on Seeking Alpha
For further details see:
Atara Biotherapeutics: Opportunity As They Sell Off Their Approved Asset For Longer Runway